AUPH vs. GILD
Compare and contrast key facts about Aurinia Pharmaceuticals Inc. (AUPH) and Gilead Sciences, Inc. (GILD).
Performance
AUPH vs. GILD - Performance Comparison
Loading graphics...
AUPH vs. GILD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AUPH Aurinia Pharmaceuticals Inc. | -2.13% | 77.62% | -0.11% | 108.10% | -81.11% | 65.37% | -31.74% | 197.07% | 50.55% | 115.71% |
GILD Gilead Sciences, Inc. | 14.47% | 36.59% | 18.68% | -1.99% | 23.63% | 29.95% | -6.70% | 7.88% | -9.92% | 2.96% |
Fundamentals
AUPH:
$2.17B
GILD:
$175.06B
AUPH:
$2.06
GILD:
$6.79
AUPH:
7.57
GILD:
20.59
AUPH:
0.00
GILD:
0.05
AUPH:
7.68
GILD:
5.95
AUPH:
3.72
GILD:
7.74
AUPH:
$283.06M
GILD:
$29.44B
AUPH:
$250.39M
GILD:
$23.79B
AUPH:
$109.83M
GILD:
$12.90B
Returns By Period
In the year-to-date period, AUPH achieves a -2.13% return, which is significantly lower than GILD's 14.47% return. Over the past 10 years, AUPH has outperformed GILD with an annualized return of 17.93%, while GILD has yielded a comparatively lower 7.76% annualized return.
AUPH
- 1D
- 0.90%
- 1M
- 10.32%
- YTD
- -2.13%
- 6M
- 38.63%
- 1Y
- 90.60%
- 3Y*
- 14.79%
- 5Y*
- 3.51%
- 10Y*
- 17.93%
GILD
- 1D
- -0.42%
- 1M
- -4.96%
- YTD
- 14.47%
- 6M
- 27.92%
- 1Y
- 28.18%
- 3Y*
- 22.94%
- 5Y*
- 20.43%
- 10Y*
- 7.76%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AUPH vs. GILD — Risk / Return Rank
AUPH
GILD
AUPH vs. GILD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aurinia Pharmaceuticals Inc. (AUPH) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| AUPH | GILD | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.01 | 0.98 | +1.03 |
Sortino ratioReturn per unit of downside risk | 2.63 | 1.58 | +1.06 |
Omega ratioGain probability vs. loss probability | 1.37 | 1.18 | +0.19 |
Calmar ratioReturn relative to maximum drawdown | 5.90 | 2.10 | +3.81 |
Martin ratioReturn relative to average drawdown | 12.85 | 5.65 | +7.20 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| AUPH | GILD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.01 | 0.98 | +1.03 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.05 | 0.86 | -0.81 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.24 | 0.30 | -0.06 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.17 | 0.39 | -0.22 |
Correlation
The correlation between AUPH and GILD is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
AUPH vs. GILD - Dividend Comparison
AUPH has not paid dividends to shareholders, while GILD's dividend yield for the trailing twelve months is around 2.28%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AUPH Aurinia Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GILD Gilead Sciences, Inc. | 2.28% | 2.57% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
Drawdowns
AUPH vs. GILD - Drawdown Comparison
The maximum AUPH drawdown since its inception was -87.58%, which is greater than GILD's maximum drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for AUPH and GILD.
Loading graphics...
Drawdown Indicators
| AUPH | GILD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -87.58% | -70.83% | -16.75% |
Max Drawdown (1Y)Largest decline over 1 year | -15.91% | -13.77% | -2.14% |
Max Drawdown (5Y)Largest decline over 5 years | -87.58% | -26.59% | -60.99% |
Max Drawdown (10Y)Largest decline over 10 years | -87.58% | -36.01% | -51.57% |
Current DrawdownCurrent decline from peak | -52.81% | -9.82% | -42.99% |
Average DrawdownAverage peak-to-trough decline | -49.17% | -22.20% | -26.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.31% | 5.12% | +2.19% |
Volatility
AUPH vs. GILD - Volatility Comparison
Aurinia Pharmaceuticals Inc. (AUPH) has a higher volatility of 12.15% compared to Gilead Sciences, Inc. (GILD) at 6.34%. This indicates that AUPH's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| AUPH | GILD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.15% | 6.34% | +5.81% |
Volatility (6M)Calculated over the trailing 6-month period | 26.73% | 18.92% | +7.81% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.41% | 29.00% | +16.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 68.68% | 23.89% | +44.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 74.41% | 25.63% | +48.78% |
Financials
AUPH vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between Aurinia Pharmaceuticals Inc. and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities